Growth Metrics

Rhythm Pharmaceuticals (RYTM) Non-Current Deferred Tax Liability (2021)

Rhythm Pharmaceuticals (RYTM) has disclosed Non-Current Deferred Tax Liability for 1 consecutive years, with $8.0 million as the latest value for Q3 2021.